Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Keith F. Barker"'
Publikováno v:
Molecular Phylogenetics and Evolution. 69:299-305
The Nesospiza finches of the Tristan da Cunha archipelago and Rowettia goughensis from Gough Island, 380 km distant, are both derived from tanager-finches (Thraupidae) that colonized the islands by crossing more than 3000 km of ocean from South Ameri
Autor:
Zhou Xiaqiu, Xu Daozhen, Hou JinLin, Zeng Min-de, Jonathan S. Dixon, Keith F. Barker, Mao Yi-min, Ren Hong, Chen Youming, Niu Jun-qi, Wang Yaozong, Yao Guangbi, Wang Yuming, Wang Hao, Chen Yagang
Publikováno v:
Liver International. 32:137-146
Background Adefovir dipivoxil (ADV) is a nucleotide analogue with proven efficacy in chronic hepatitis B (CHB). Aims This study investigated long-term ADV treatment in HBeAg-positive patients. Methods A total of 480 Chinese subjects with HBeAg-positi
Publikováno v:
Behaviour. 146:1-43
The traditionally-defined wren genus Thryothorus is notable for its diversity of singing styles with some species producing highly coordinated duets or choruses in various formats while, at the other extreme, songs are performed almost exclusively by
Publikováno v:
Hepatology International. 2:440-456
The development of antiviral resistance is a recognized challenge to successful treatment of chronic hepatitis B (CHB), but it has been difficult to establish an accurate estimate of its incidence due to a number of factors: (a) lack of an accepted d
Autor:
Keith F. Barker
Publikováno v:
British Journal of Clinical Pharmacology. 48:109-124
The impact of antimicrobial agents on public health over the past 50 years is unmatched by any other therapeutic class. Precise data on current antibiotic use are difficult to obtain; in the UK, in the community alone, there are over 50 million presc
Autor:
GuangBi Yao, Beulah Ji, Keith F. Barker, Minde Zeng, Chai-Ni P. Chang, Yi-Min Mao, YaoZong Wang, Jinlin Hou, Hao Wang
Publikováno v:
Hepatology (Baltimore, Md.). 44(1)
Four hundred and eighty Chinese subjects with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) were enrolled in a multicenter, double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) 10 mg once daily. There was
Publikováno v:
Journal of Infection. 24:214-215